Source | ||||||
---|---|---|---|---|---|---|
Category | Competency | JRCALC guideline | Inventory | Patient care forms | Observation | Provider survey |
Condition | COPD | • | • | • | • | |
Dyspnoea | • | • | • | • | ||
Pneumonia | • | • | • | • | ||
Pneumothorax | • | • | ||||
Heart failure | • | • | • | • | • | |
Pulmonary embolism | • | • | • | |||
Lung cancer | • | • | ||||
Anaphylaxis | • | • | ||||
Airway obstruction | • | • | • | • | ||
Hypoxia | • | • | • | • | ||
Diagnostic | Current medication | • | • | • | • | |
Past medical history | • | • | • | • | ||
Timeline of events | • | • | • | • | ||
Airway patency | • | • | • | • | ||
Respiratory rate | • | • | • | • | ||
Breathing pattern | • | • | • | • | ||
Auscultation of lungs | • | • | • | • | • | |
Cyanosis | • | • | • | |||
Pulse oxymeter monitoring | • | • | • | • | • | |
ECG monitoring | • | • | • | • | • | |
Medication | Salbutamol (nebulised) | • | • | • | • | • |
Ipratropium bromide (nebulised) | • | • | • | • | ||
High flow oxygen | • | • | • | • | • | |
Intervention | Intravenous cannulation | • | • | • | • | • |
Oxygen (titrated to 90%–92%) | • | • | • | • | ||
Clinical decision | Clinical response to nebulised salbutamol | • | • | • |
• a given competency was identified.